Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.22B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Danaher
DHR
|
+$293M |
| 4 |
Linde
LIN
|
+$281M |
| 5 |
Carlyle Group
CG
|
+$268M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$926M |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$770M |
| 3 |
iShares Bitcoin Trust
IBIT
|
+$649M |
| 4 |
Meta Platforms (Facebook)
META
|
+$641M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$462M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9% |
| 2 | Technology | 7.77% |
| 3 | Healthcare | 6.87% |
| 4 | Industrials | 5.57% |
| 5 | Consumer Discretionary | 5.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
PUT
PVH
PVH
$4.16B
| $2.62M | ﹤0.01% |
+40,600
| New | +$3.28M |
|
|
MOFG
3402
DELISTED
MidWestOne Financial Group
MOFG
| $2.62M | ﹤0.01% |
88,608
-22,369
| -20% | -$675K |
|
3403
South Plains Financial
SPFI
$853M
| $2.62M | ﹤0.01% |
79,173
-15,159
| -16% | -$522K |
|
3404
Praxis Precision Medicines
PRAX
$8.73B
| $2.62M | ﹤0.01% |
69,181
-81,711
| -54% | -$5.1M |
|
3405
Immunovant
IMVT
$8.03B
| $2.62M | ﹤0.01% |
153,240
+6,143
| +4% | +$129K |
|
3406
Enliven Therapeutics
ELVN
$4.14B
| $2.62M | ﹤0.01% |
132,887
+82,083
| +162% | +$1.77M |
|
3407
CVB Financial
CVBF
$4.05B
| $2.62M | ﹤0.01% |
141,669
-34,996
| -20% | -$697K |
|
3408
Tompkins Financial
TMP
$1.46B
| $2.61M | ﹤0.01% |
41,520
+20,522
| +98% | +$1.37M |
|
3409
PUT
XPO
XPO
$23.5B
| $2.61M | ﹤0.01% |
24,300
+14,300
| +143% | +$1.82M |
|
3410
CALL
Viatris
VTRS
$20.6B
| $2.61M | ﹤0.01% |
+300,000
| New | +$3.15M |
|
3411
PUT
Coca-Cola Europacific Partners
CCEP
$47.5B
| $2.61M | ﹤0.01% |
+30,000
| New | +$2.45M |
|
|
PPLI
3412
People Inc
PPLI
$3.34B
| $2.61M | ﹤0.01% |
69,277
-234,989
| -77% | -$8.57M |
|
3413
United States Antimony
UAMY
$947M
| $2.61M | ﹤0.01% |
1,186,582
+1,085,789
| +1,077% | +$1.88M |
|
3414
CALL
NeoGenomics
NEO
$2.06B
| $2.61M | ﹤0.01% |
+275,000
| New | +$3.43M |
|
3415
PUT
Carpenter Technology
CRS
$28.8B
| $2.61M | ﹤0.01% |
14,400
+12,300
| +586% | +$2.37M |
|
3416
CALL
Williams-Sonoma
WSM
$29.4B
| $2.61M | ﹤0.01% |
16,500
-1,100
| -6% | -$213K |
|
3417
Harmony Biosciences
HRMY
$2.22B
| $2.61M | ﹤0.01% |
78,492
+72,159
| +1,139% | +$2.59M |
|
3418
Theravance Biopharma
TBPH
$875M
| $2.6M | ﹤0.01% |
291,534
+98,695
| +51% | +$918K |
|
3419
PUT
CAVA Group
CAVA
$7.79B
| $2.6M | ﹤0.01% |
30,100
+14,400
| +92% | +$1.56M |
|
3420
Pacific Biosciences
PACB
$435M
| $2.6M | ﹤0.01% |
2,204,044
-14,861,287
| -87% | -$22.8M |
|
3421
SiTime
SITM
$16.7B
| $2.6M | ﹤0.01% |
17,005
+9,661
| +132% | +$1.85M |
|
3422
LifeMD
LFMD
$185M
| $2.59M | ﹤0.01% |
476,462
-409,525
| -46% | -$2.32M |
|
3423
Omeros
OMER
$932M
| $2.59M | ﹤0.01% |
315,252
+229,581
| +268% | +$2.03M |
|
3424
Lakeland Industries
LAKE
$122M
| $2.59M | ﹤0.01% |
127,465
+99,682
| +359% | +$2.29M |
|
3425
Inspire Medical Systems
INSP
$1.74B
| $2.59M | ﹤0.01% |
16,246
+11,195
| +222% | +$2.03M |
|
Similar funds
Millennium Management's Q1 2025 Portfolio in Review
As of Q1 2025, Millennium Management held 6,639 positions worth $188B, down 8.2% from $205B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Millennium Management withdrew a net $8.86B in Q1 2025, closing 852 positions and reducing 2,261 holdings. Its most notable exit was Verizon, an estimated $263M position sold in full.
By sector, the portfolio is most concentrated in Financials at 9% of assets, up from 8.3% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Millennium Management opened a new position in Blackrock worth $215M.
- Millennium Management's largest Q1 2025 buy was Blackrock: 227,394 shares worth $215M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q1 2025, an estimated $2.22B increase.
- Millennium Management's biggest Q1 2025 reduction was Broadcom, cutting an estimated $926M.
- Millennium Management fully exited Verizon in Q1 2025, selling an estimated $263M.
- Millennium Management's ten largest holdings make up 16% of its $188B portfolio in Q1 2025.
- Millennium Management opened 739 new positions and closed 852 in Q1 2025.
- Millennium Management's portfolio value fell 8.2% quarter-over-quarter to $188B.
Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.